This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
What’s the best-performing sector in 2023? You might say something tech-related. While that is true among large-cap US equities, small and mid-sized companies within...
At a Glance In light of Lyra Therapeutics’ (NASDAQ:LYRA) recent financial and clinical data, investors face a complex investment landscape. On the clinical side,...
After Lucid Group (NASDAQ:LCID) disappointed multiple times with its delivery achievements in FY 2023 and dropped its EV prices by a considerable percentage, the...
The potential Exxon Mobil (XOM) deal to acquire Pioneer Natural Resources (PXD) should make Devon Energy (NYSE:DVN) even more appealing. The independent energy company...
Big Dividends PLUS, Blue Harbinger The BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a closed-end fund (“CEF”) that recently announced a distribution cut, and...